Therefore, FABP4 could endow colon cancer cells with mesenchymal properties, characterized by reducing cell-to-cell adhesion regulated by E-cadherin, and increasing the expressions of mesenchymal biomarkers. The gene discussed is FABP4; the disease is malignant colon neoplasm.